Ginkgetin Pretreatment Reduces Inflammatory Response in DCD Donor Liver via JAK2/STAT3 Signaling Pathway
Annals of Transplantation · 2024
DOI: 10.12659/aot.944153 ↗Kurz gefasst
Fachartikel in der Zeitschrift Annals of Transplantation, 2024. Verfasst von Jia Liu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Transplantation, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi, China. Hauptthemen laut MEDLINE: Biflavonoids, Liver, Liver Transplantation, Signal Transduction. Die Arbeit wurde bisher 4-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Transplantation, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi, China.
Zitieren
APA
Liu, J., Xiao, J., Deng, Q., Fu, Z., & Xiao, Q. (2024). Ginkgetin Pretreatment Reduces Inflammatory Response in DCD Donor Liver via JAK2/STAT3 Signaling Pathway. Annals of Transplantation. https://doi.org/10.12659/aot.944153
Vancouver
Liu J, Xiao J, Deng Q, Fu Z, Xiao Q. Ginkgetin Pretreatment Reduces Inflammatory Response in DCD Donor Liver via JAK2/STAT3 Signaling Pathway. Annals of Transplantation. 2024. doi:10.12659/aot.944153
BibTeX
@article{Liu2024,
author = {Liu, Jia and Xiao, Jiansheng and Deng, Qin and Fu, ZhiHui and Xiao, Qi},
title = {Ginkgetin Pretreatment Reduces Inflammatory Response in DCD Donor Liver via JAK2/STAT3 Signaling Pathway},
journal = {Annals of Transplantation},
year = {2024},
doi = {10.12659/aot.944153}
}
EUVIMED